Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Quesnel

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Cancer Letters|April 4, 2008
Dormant tumor cells as a therapeutic target?Bruno Quesnel
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 7, 2008
Tumor dormancy and immunoescapeBruno Quesnel
Expert Review of Vaccines|December 23, 2006
Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?Bruno Quesnel
Leukemia Research|December 17, 2008
Methyltransferases in myelodysplastic syndromes: guilty or not guilty?Bruno Quesnel
Current Research in Translational Medicine|April 25, 2018
CAR T-cells: A John von Neumann legacy?Bruno Quesnel
Advances in Experimental Medicine and Biology|November 13, 2012
Tumor dormancy: long-term survival in a hostile environmentBruno Quesnel
Leukemia Research|June 20, 2006
Methylation and myelodysplastic syndromes: when and where?Bruno Quesnel
Medecine Sciences : M/S|July 8, 2008
[Tumor dormancy: is adaptative immunity a key player?]Bruno Quesnel
Blood|June 12, 2004
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysisAurore Saudemont, Bruno Quesnel
Cancers|December 24, 2021
Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?Christian Bailly, Xavier Thuru, Bruno Quesnel
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Cancer Letters|April 4, 2008
Dormant tumor cells as a therapeutic target?Bruno Quesnel
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 7, 2008
Tumor dormancy and immunoescapeBruno Quesnel
Expert Review of Vaccines|December 23, 2006
Cancer vaccines and tumor dormancy: a long-term struggle between host antitumor immunity and persistent cancer cells?Bruno Quesnel
Leukemia Research|December 17, 2008
Methyltransferases in myelodysplastic syndromes: guilty or not guilty?Bruno Quesnel
Current Research in Translational Medicine|April 25, 2018
CAR T-cells: A John von Neumann legacy?Bruno Quesnel
Advances in Experimental Medicine and Biology|November 13, 2012
Tumor dormancy: long-term survival in a hostile environmentBruno Quesnel
Leukemia Research|June 20, 2006
Methylation and myelodysplastic syndromes: when and where?Bruno Quesnel
Medecine Sciences : M/S|July 8, 2008
[Tumor dormancy: is adaptative immunity a key player?]Bruno Quesnel
Blood|June 12, 2004
In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysisAurore Saudemont, Bruno Quesnel
Cancers|December 24, 2021
Modulation of the Gal-9/TIM-3 Immune Checkpoint with α-Lactose. Does Anomery of Lactose Matter?Christian Bailly, Xavier Thuru, Bruno Quesnel
Pageof 16